Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA “Breakthrough” Designation Bill Revives Debate About Legislating Flexibility

Mar 27 2012

• By Derrick Gingery

Related Content

How "Clean" Will PDFUA V Be? Rep. Pitts Explains His Vacuuming Technique

Jul 18 2011

Regulatory Flexibility Staring Contest: Will Industry Or FDA Blink First?

Oct 24 2011

Orphan Products Mostly Approved With Regulatory Flexibility, NORD "Catalog" Finds

Oct 17 2011

FDA Expanding Accelerated Approval Through Guidance, Collaboration

Mar 12 2012

Synchronized Regulation: Tandem Approvals Of <em>Xalkori</em>, Diagnostic Required Considerable Coordination

Mar 01 2012

BIO Wants Expanded Accelerated Approval In PDUFA Instead Of Progressive Approval

Jan 23 2012

FDA Biomedical Innovation Initiative Draws On Familiar Themes

Oct 10 2011

Related Companies

Pfizer Inc.

Additional Topics

United States Legislation Regulation Drug Approval Standards BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window